What are the discontinuation criteria for Brivaracetam/Brivaracetam?

Brivaracetam/Brivaracetam is a new generation anti-epileptic drug that is widely used in the long-term control of partial seizures in adults and adolescents. Given the chronic and relapsing nature of epilepsy, antiepileptic drugs often require long-term maintenance treatment. However, some patients may need to consider discontinuing brivaracetam if they have been seizure-free for a long time or due to side effects, pregnancy preparation, drug replacement, etc. At this time, reasonable drug withdrawal standards and strategies are particularly critical to avoid epilepsy recurrence or withdrawal reactions.

First of all, although brivaracetam is considered to have low addiction and drug resistance, it is closely related to the stability of the central nervous system. Sudden discontinuation of the drug may cause a rebound in neurological excitement and induce severe epileptic seizures, especially status epilepticus. Therefore, any discontinuation of medication should be done in a gradual manner. Before stopping the drug, it is recommended to have at least two years of complete seizure-free record, and professional doctors to evaluate multiple indicators such as electroencephalography, cause stability, and neuroimaging to ensure that the disease is in a stable remission period.

Secondly, brivaracetam should be discontinued by gradually reducing the dose. Depending on the dose and period of medication the patient takes, the tapering cycle may last from several weeks to several months. Especially in patients taking concomitant medications, if brivaracetam needs to be discontinued and otherAEDs retained, special attention should be paid to adjusting the doses of other drugs to maintain therapeutic balance. In addition, for patients with epileptic seizure triggers, such as metabolic disorders, infection, or mental stress, it is recommended to postpone discontinuation of medication until the overall condition is stable before evaluating the feasibility.

During the withdrawal process, the patient's neurological symptoms, including changes in consciousness, mood swings, sleep structure disorders, etc., need to be closely monitored, and the patient should be instructed to maintain a regular schedule and avoid excessive fatigue and strong emotional stimulation. For those who have a history of drug withdrawal relapse or those who are prone to hereditary epilepsy, it is usually not recommended to interrupt treatment easily.

Reference materials:https://www.briviact.com/